454 related articles for article (PubMed ID: 25815329)
1. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities.
Tedaldi EM; Minniti NL; Fischer T
Biomed Res Int; 2015; 2015():641913. PubMed ID: 25815329
[TBL] [Abstract][Full Text] [Related]
2. Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.
Tymchuk S; Gomez D; Koenig N; Gill MJ; Fujiwara E; Power C
Can J Psychiatry; 2018 May; 63(5):329-336. PubMed ID: 29228820
[TBL] [Abstract][Full Text] [Related]
3. Relationship between sleep parameters and cognitive performance in HIV-positive individuals.
Kawada T
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e124. PubMed ID: 24525472
[No Abstract] [Full Text] [Related]
4. Neurocognition in individuals co-infected with HIV and hepatitis C.
Hinkin CH; Castellon SA; Levine AJ; Barclay TR; Singer EJ
J Addict Dis; 2008; 27(2):11-7. PubMed ID: 18681187
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
Heaton RK; Clifford DB; Franklin DR; Woods SP; Ake C; Vaida F; Ellis RJ; Letendre SL; Marcotte TD; Atkinson JH; Rivera-Mindt M; Vigil OR; Taylor MJ; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I;
Neurology; 2010 Dec; 75(23):2087-96. PubMed ID: 21135382
[TBL] [Abstract][Full Text] [Related]
6. Evaluating sleep and cognition in HIV.
Gamaldo CE; Gamaldo A; Creighton J; Salas RE; Selnes OA; David PM; Mbeo G; Parker BS; Brown A; McArthur JC; Smith MT
J Acquir Immune Defic Syndr; 2013 Aug; 63(5):609-16. PubMed ID: 23722610
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive disturbances in HIV.
Grant I
Int Rev Psychiatry; 2008 Feb; 20(1):33-47. PubMed ID: 18240061
[TBL] [Abstract][Full Text] [Related]
9. The persistence of HIV-associated neurocognitive dysfunction and the effects of comorbidities.
Cohen RA; Gongvatana A
Neurology; 2010 Dec; 75(23):2052-3. PubMed ID: 21135377
[No Abstract] [Full Text] [Related]
10. Microvascular Function in Aging Among Women Living with HIV.
Monsuez JJ; Belin C; Bouchaud O
Curr HIV/AIDS Rep; 2016 Dec; 13(6):392-398. PubMed ID: 27709330
[TBL] [Abstract][Full Text] [Related]
11. Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.
Clark US; Cohen RA
Curr Opin Investig Drugs; 2010 Aug; 11(8):884-900. PubMed ID: 20721831
[TBL] [Abstract][Full Text] [Related]
12. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
[TBL] [Abstract][Full Text] [Related]
13. HIV-Associated Neurocognitive Disorder (HAND): Relative Risk Factors.
Kompella S; Al-Khateeb T; Riaz OA; Orimaye SO; Sodeke PO; Awujoola AO; Ikekwere J; Goodkin K
Curr Top Behav Neurosci; 2021; 50():401-426. PubMed ID: 32720161
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cognitive disorders differs as a function of age in HIV virus infection.
Becker JT; Lopez OL; Dew MA; Aizenstein HJ
AIDS; 2004 Jan; 18 Suppl 1():S11-8. PubMed ID: 15075493
[TBL] [Abstract][Full Text] [Related]
15. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
16. Successful cognitive aging in persons living with HIV infection.
Malaspina L; Woods SP; Moore DJ; Depp C; Letendre SL; Jeste D; Grant I;
J Neurovirol; 2011 Feb; 17(1):110-9. PubMed ID: 21165783
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders.
Robertson K; Yosief S
Semin Neurol; 2014 Feb; 34(1):21-6. PubMed ID: 24715485
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.
Nichols SL; Bethel J; Garvie PA; Patton DE; Thornton S; Kapogiannis BG; Ren W; Major-Wilson H; Puga A; Woods SP
J Adolesc Health; 2013 Dec; 53(6):763-71. PubMed ID: 23972941
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders.
Moulignier A; Costagliola D
Curr Top Behav Neurosci; 2021; 50():367-399. PubMed ID: 31989463
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.
Mohamed AA; Oduor C; Kinyanjui D
BMC Neurol; 2020 Jul; 20(1):280. PubMed ID: 32664858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
